Clinical Trial Update: A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of K-604 for the treatment of atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• K-604

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Atherosclerosis | Phase 2 | Status: COMPLETED